The current valuation score of FibroGen Inc is 8.32, ranking 52 out of 398 in the Biotechnology & Medical Research industry. Its current P/E ratio is 0.18, which is 3.41% below the recent high of 0.19 and 15981.12% above the recent low of -28.86.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.